Literature DB >> 27584817

Novel Metrics in the Longitudinal Evaluation of Pain Data in Sickle Cell Disease.

Nitya Bakshi1, Meagan E Smith, Diana Ross, Lakshmanan Krishnamurti.   

Abstract

BACKGROUND: Available modalities for the longitudinal capture and analysis of pain intensity in patients with sickle cell disease (SCD) limit our ability to study intraindividual and interindividual variation in pain and the factors influencing the transition from acute to chronic pain in patients with SCD.
OBJECTIVES: The objectives of this study were to determine the feasibility of electronic capture of longitudinal outpatient pain intensity data and to test the applicability of novel metrics in the study of intraindividual and interindividual variation in pain in patients with SCD.
MATERIALS AND METHODS: Twenty SCD patients aged 13 to 21 submitted 2045 diary days of pain intensity data over 229 days using a web-based electronic pain diary or through text message.
RESULTS: Participants reported pain (11-point Numerical Rating Score >0) on 1559 diary days (76.2%) suggesting a significant outpatient pain burden. In addition to mean maximum daily pain (MMDP), using maximum daily pain (MDP) scores, we calculated the ninetieth percentile (p90) of MDP, proportion of pain-free days (PPFD), Standard Deviation (SD) of MDP and coefficient of variation (CV) of MDP. Although p50 of MDP and p90 of MDP correlated positively with MMDP, PPFD correlated negatively with MMDP and both MMDP and PPFD correlated poorly with the SD of MDP. Examination of graphic representation of pain trends demonstrated how patients with similar MMDP had varying p90, PPFD, SD/coefficient of variation, and ultimately burden of pain over time. Missing data rates were lowest in the first 30 days of reporting and increased over time. Study participants reported a positive experience with momentary pain reporting and improved communication with health care providers regarding pain.
CONCLUSIONS: The longitudinal collection of pain data with the inclusion of hospital data during periods of hospitalization is feasible and acceptable in patients with SCD over periods of 30 to 60 days. Long-term collection of pain diary data, while informative, is associated with higher rates of missing data. Novel metrics of pain have the potential to better describe intraindividual and interindividual variation in pain, inform studies of the transition from acute to chronic pain as well as contribute patient-reported end points of pain for interventional clinical trials of pain in SCD.

Entities:  

Mesh:

Year:  2017        PMID: 27584817     DOI: 10.1097/AJP.0000000000000431

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  10 in total

1.  Predictive Ability of Intermittent Daily Sickle Cell Pain Assessment: The PiSCES Project.

Authors:  Wally R Smith; Donna K McClish; James Levenson; Imoigele Aisiku; Bassam Dahman; Viktor E Bovbjerg; Susan Roseff; John Roberts
Journal:  Pain Med       Date:  2018-10-01       Impact factor: 3.750

2.  Intraindividual pain variability and phenotypes of pain in sickle cell disease: a secondary analysis from the Pain in Sickle Cell Epidemiology Study.

Authors:  Nitya Bakshi; Scott Gillespie; Donna McClish; Courtney McCracken; Wally R Smith; Lakshmanan Krishnamurti
Journal:  Pain       Date:  2021-09-17       Impact factor: 7.926

3.  Changes in Pain and Psychosocial Functioning and Transition to Chronic Pain in Pediatric Sickle Cell Disease: A Cohort Follow-up Study.

Authors:  Soumitri Sil; Lindsey L Cohen; Nitya Bakshi; Amanda Watt; Morgan Hathaway; Farida Abudulai; Carlton Dampier
Journal:  Clin J Pain       Date:  2020-06       Impact factor: 3.442

4.  Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers.

Authors:  Debra D Pittman; Patrick C Hines; David Beidler; Denis Rybin; Andrew L Frelinger; Alan D Michelson; Ke Liu; Xiufeng Gao; Jennell White; Ahmar U Zaidi; Robert J Charnigo; Michael U Callaghan
Journal:  Blood       Date:  2021-04-15       Impact factor: 22.113

5.  Patient-Centered eHealth Interventions for Children, Adolescents, and Adults With Sickle Cell Disease: Systematic Review.

Authors:  Sherif M Badawy; Robert M Cronin; Jane Hankins; Lori Crosby; Michael DeBaun; Alexis A Thompson; Nirmish Shah
Journal:  J Med Internet Res       Date:  2018-07-19       Impact factor: 5.428

6.  Availability of researcher-led eHealth tools for pain assessment and management: barriers, facilitators, costs, and design.

Authors:  Kristen S Higgins; Perri R Tutelman; Christine T Chambers; Holly O Witteman; Melanie Barwick; Penny Corkum; Doris Grant; Jennifer N Stinson; Chitra Lalloo; Sue Robins; Rita Orji; Isabel Jordan
Journal:  Pain Rep       Date:  2018-09-11

7.  Clusters of pain trajectories among patients with sickle cell disease hospitalized for vaso-occlusive crisis: a data-driven approach.

Authors:  Angie Mae Rodday; Kimberly S Esham; Nicole Savidge; Susan K Parsons
Journal:  EJHaem       Date:  2020-10-22

8.  A Stress and Pain Self-management mHealth App for Adult Outpatients With Sickle Cell Disease: Protocol for a Randomized Controlled Study.

Authors:  Miriam O Ezenwa; Yingwei Yao; Molly W Mandernach; David A Fedele; Robert J Lucero; Inge Corless; Brenda W Dyal; Mary H Belkin; Abhinav Rohatgi; Diana J Wilkie
Journal:  JMIR Res Protoc       Date:  2022-07-29

9.  II. Indices of Pain Intensity Derived From Ecological Momentary Assessments and Their Relationships With Patient Functioning: An Individual Patient Data Meta-analysis.

Authors:  Stefan Schneider; Doerte U Junghaenel; Joan E Broderick; Masakatsu Ono; Marcella May; Arthur A Stone
Journal:  J Pain       Date:  2020-10-24       Impact factor: 5.820

10.  Temporal dynamics of pain: an application of regime-switching models to ecological momentary assessments in patients with rheumatic diseases.

Authors:  Stefan Schneider; Doerte U Junghaenel; Masakatsu Ono; Arthur A Stone
Journal:  Pain       Date:  2018-07       Impact factor: 7.926

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.